Craneware plc (AIM:CRW)
London · Delayed Price · Currency is GBP · Price in GBX 1,453.70
+1.70 (0.12%)
Jun 17, 2026, 9:09 AM GMT
Craneware Market Cap
Craneware has a market cap or net worth of 492.52 million as of June 16, 2026. Its market cap has decreased by -32.06% in one year.
Market Cap
492.52M
Enterprise Value
482.08M
Revenue
157.02M
Ranking
n/a
PE Ratio
31.12
Stock Price
1,453.70
Market Cap Chart
Since September 13, 2007, Craneware's market cap has increased from 27.00M to 492.52M, an increase of 1,724.47%. That is a compound annual growth rate of 16.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 17, 2026 | 492.52M | -27.24% |
| Dec 31, 2025 | 676.88M | -8.39% |
| Dec 31, 2024 | 738.88M | 20.69% |
| Dec 29, 2023 | 612.23M | -3.93% |
| Dec 30, 2022 | 637.29M | -26.03% |
| Dec 31, 2021 | 861.52M | 41.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 206.03B |
| GSK plc | 78.16B |
| Haleon | 29.53B |
| Smith & Nephew | 9.60B |
| Spire Healthcare Group | 867.29M |
| CVS Group | 852.40M |
| Oxford Biomedica | 726.73M |
| Allergy Therapeutics | 500.27M |